Zeniya M - Search Results

1

The therapeutic effect of UDCA is a factor in determining the prognosis of primary biliary cirrhosis.

Zeniya M, Wada T. Zeniya M, et al. J Gastroenterol. 2014 Oct;49(10):1438-9. doi: 10.1007/s00535-014-0969-4. Epub 2014 Jun 5. J Gastroenterol. 2014. PMID: 24898105 No abstract available.

2

Immunosuppressive therapy for primary biliary cirrhosis: Do we need in future?

Zeniya M, Wada T. Zeniya M, et al. Hepatol Res. 2014 Sep;44(9):935-6. doi: 10.1111/hepr.12245. Hepatol Res. 2014. PMID: 25224130 No abstract available.

3

Background of the FIB-4 index in Japanese non-alcoholic fatty liver disease.

Wada T, Zeniya M. Wada T, et al. Among authors: zeniya m. Intern Med. 2015;54(2):127-32. doi: 10.2169/internalmedicine.54.2685. Epub 2015 Jan 15. Intern Med. 2015. PMID: 25743002 Free article.

4

Fatty liver and serum cholinesterase are independently correlated with HbA1c levels: cross-sectional analysis of 5384 people.

Katoh S, Peltonen M, Wada T, Zeniya M, Sakamoto Y, Utsunomiya K, Tuomilehto J. Katoh S, et al. Among authors: zeniya m. J Int Med Res. 2014 Apr;42(2):542-53. doi: 10.1177/0300060513517485. Epub 2014 Mar 4. J Int Med Res. 2014. PMID: 24595150 Free article.

5

IgM response is a prognostic biomarker of primary biliary cholangitis treated with ursodeoxycholic acid and bezafibrate.

Takano K, Saeki C, Oikawa T, Hidaka A, Mizuno Y, Ishida J, Takakura K, Nakano M, Torisu Y, Amano K, Ishikawa T, Zeniya M, Tsubota A, Saruta M. Takano K, et al. Among authors: zeniya m. J Gastroenterol Hepatol. 2020 Apr;35(4):663-672. doi: 10.1111/jgh.14900. Epub 2019 Dec 11. J Gastroenterol Hepatol. 2020. PMID: 31677185

6

Detection of serum nitrite and nitrate in primary biliary cirrhosis: possible role of nitric oxide in bile duct injury.

Hokari A, Zeniya M, Esumi H, Kawabe T, Gershwin ME, Toda G. Hokari A, et al. Among authors: zeniya m. J Gastroenterol Hepatol. 2002 Mar;17(3):308-15. doi: 10.1046/j.1440-1746.2002.02689.x. J Gastroenterol Hepatol. 2002. PMID: 11982702

7

Diagnosing clinical subsets of autoimmune liver diseases based on a multivariable model.

Zeniya M, Watanabe F, Morizane T, Shibata M, Maeyama S, Kage M, Nakanuma Y, Toda G; Study Group of Intractable Liver Diseases for Research on a Specific Disease, Health Science Research Grant, Ministry of Health, Labour, and Welfare of Japan. Zeniya M, et al. J Gastroenterol. 2005 Dec;40(12):1148-54. doi: 10.1007/s00535-005-1713-x. J Gastroenterol. 2005. PMID: 16378179

8

Application and validation of a new histologic staging and grading system for primary biliary cirrhosis.

Harada K, Hsu M, Ikeda H, Zeniya M, Nakanuma Y. Harada K, et al. Among authors: zeniya m. J Clin Gastroenterol. 2013 Feb;47(2):174-81. doi: 10.1097/MCG.0b013e31827234e4. J Clin Gastroenterol. 2013. PMID: 23269312

9

Autoimmune hepatitis in Japan: trends in a nationwide survey.

Takahashi A, Arinaga-Hino T, Ohira H, Torimura T, Zeniya M, Abe M, Yoshizawa K, Takaki A, Suzuki Y, Kang JH, Nakamoto N, Fujisawa T, Yonemoto K, Tanaka A, Takikawa H; Autoimmune Hepatitis Study Group-Subgroup of the Intractable Hepato-Biliary Disease Study Group in Japan. Takahashi A, et al. Among authors: zeniya m. J Gastroenterol. 2017 May;52(5):631-640. doi: 10.1007/s00535-016-1267-0. Epub 2016 Oct 8. J Gastroenterol. 2017. PMID: 27722997

10

New weapon for primary biliary cirrhosis from Japan.

Zeniya M. Zeniya M. J Gastroenterol. 2003;38(6):619-20. J Gastroenterol. 2003. PMID: 12858848 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

157 results

Search Page